B

시지메드텍

056090KOSDAQ

56.5 / 100

Reference Date: 2026-10-23

Financial Score21.0 / 40
News Sentiment12.5 / 25
Momentum13.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Surged 293.7% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Sijimedtec operates in two main business divisions: medical devices and electrical energy. In the medical devices sector, the company has developed a range of products including spinal fixation devices, fracture treatment devices, and biodegradable implants, and has expanded into dental implants through acquisitions. In the electrical energy division, the company has secured technology in smart grids and EV charging infrastructure, and participates in government-led projects.

Number of Employees

118people

Average Salary

51.1M KRW

Score Calculation Basis

Detailed Financial Score

PER
74.37Industry Average 15.000.0Point

5.0x industry avg (risky)

PBR
1.03Industry Average 1.204.0Point

In line with industry avg

ROE
7.19Industry Average 8.002.5Point

Below industry avg

Debt Ratio
4.51Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲17.7% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲236.4% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 3.1% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position6.0Point

52w upper range (73%)

Current 4,685Won52-week high 6,07052-week low 864
1-month return6.0Point

1m +293.70% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-10-15
  • Neutral주권매매거래정지해제 (액면병합 주권 변경상장)2026-10-06